This aligns with reports that high claudin expression can confer drug resistance; for instance, claudin-7 and claudin-1/2 upregulation promotes Cisplatin resistance in pancreatic and lung cancer cells [22]. This evidence concerns the gene CLDN1 and lung carcinoma.